MLYS
Price
$38.06
Change
-$2.40 (-5.93%)
Updated
Oct 3 closing price
Capitalization
2.95B
37 days until earnings call
PTGX
Price
$64.83
Change
-$0.15 (-0.23%)
Updated
Oct 3 closing price
Capitalization
4.04B
31 days until earnings call
Interact to see
Advertisement

MLYS vs PTGX

Header iconMLYS vs PTGX Comparison
Open Charts MLYS vs PTGXBanner chart's image
Mineralys Therapeutics
Price$38.06
Change-$2.40 (-5.93%)
Volume$958.86K
Capitalization2.95B
Protagonist Therapeutics
Price$64.83
Change-$0.15 (-0.23%)
Volume$623.63K
Capitalization4.04B
MLYS vs PTGX Comparison Chart in %
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. PTGX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Buy and PTGX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (MLYS: $38.06 vs. PTGX: $64.83)
Brand notoriety: MLYS and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 52% vs. PTGX: 70%
Market capitalization -- MLYS: $2.95B vs. PTGX: $4.04B
MLYS [@Biotechnology] is valued at $2.95B. PTGX’s [@Biotechnology] market capitalization is $4.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 2 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • MLYS’s TA Score: 2 bullish, 6 bearish.
  • PTGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than MLYS.

Price Growth

MLYS (@Biotechnology) experienced а -4.83% price change this week, while PTGX (@Biotechnology) price change was -3.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2025.

PTGX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($4.04B) has a higher market cap than MLYS($2.95B). MLYS YTD gains are higher at: 209.180 vs. PTGX (67.953). PTGX has higher annual earnings (EBITDA): 26.8M vs. MLYS (-203.01M). PTGX has more cash in the bank: 570M vs. MLYS (325M). PTGX has higher revenues than MLYS: PTGX (209M) vs MLYS (0).
MLYSPTGXMLYS / PTGX
Capitalization2.95B4.04B73%
EBITDA-203.01M26.8M-757%
Gain YTD209.18067.953308%
P/E RatioN/A89.01-
Revenue0209M-
Total Cash325M570M57%
Total DebtN/A11.3M-
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
63
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSPTGX
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 21 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGHCX192.962.17
+1.14%
Vanguard Health Care Inv
FRNRX34.760.22
+0.64%
Franklin Natural Resources A
FBLAX12.830.02
+0.16%
Franklin Managed Income A
SMEAX15.900.02
+0.13%
Invesco Small Cap Equity A
CHAIX17.87-0.14
-0.78%
Chase Growth Institutional

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with CYTK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-5.93%
CYTK - MLYS
52%
Loosely correlated
+1.15%
IONS - MLYS
51%
Loosely correlated
+1.10%
BIESF - MLYS
45%
Loosely correlated
N/A
NEVPF - MLYS
43%
Loosely correlated
N/A
PTGX - MLYS
38%
Loosely correlated
-0.23%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been closely correlated with BIESF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTGX jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
-0.23%
BIESF - PTGX
66%
Closely correlated
N/A
DNLI - PTGX
41%
Loosely correlated
+1.45%
TRVI - PTGX
40%
Loosely correlated
+3.35%
MLYS - PTGX
38%
Loosely correlated
-5.93%
ORMP - PTGX
37%
Loosely correlated
-2.93%
More